CN105503569A - Synthetic method for Netupitant intermediate 2-(3,5-bi-trifluoromethyl-phenyl)-2-methyl-propionic acid - Google Patents

Synthetic method for Netupitant intermediate 2-(3,5-bi-trifluoromethyl-phenyl)-2-methyl-propionic acid Download PDF

Info

Publication number
CN105503569A
CN105503569A CN201610013748.4A CN201610013748A CN105503569A CN 105503569 A CN105503569 A CN 105503569A CN 201610013748 A CN201610013748 A CN 201610013748A CN 105503569 A CN105503569 A CN 105503569A
Authority
CN
China
Prior art keywords
trifluoromethyl
phenyl
compound
synthetic method
rnethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610013748.4A
Other languages
Chinese (zh)
Inventor
李勇刚
汪迅
王卓
凌驾越
顾波
张珍
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SUZHOU HUIHE PHARMACEUTICAL Co Ltd
Original Assignee
SUZHOU HUIHE PHARMACEUTICAL Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SUZHOU HUIHE PHARMACEUTICAL Co Ltd filed Critical SUZHOU HUIHE PHARMACEUTICAL Co Ltd
Priority to CN201610013748.4A priority Critical patent/CN105503569A/en
Publication of CN105503569A publication Critical patent/CN105503569A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/353Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by isomerisation; by change of size of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/09Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/377Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups
    • C07C51/38Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups by decarboxylation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/333Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
    • C07C67/343Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms

Abstract

The invention discloses a synthetic method for Netupitant intermediate 2-(3,5-bi-trifluoromethyl-phenyl)-2-methyl-propionic acid. The synthetic method includes the steps that a compound 3,5-bi(trifluoromethyl) bromobenzene is used as a raw material and reacts with diethyl malonate in first solvent in the presence of a first alkali reagent to produce a first compound, then the first compound is subjected to saponification and decarboxylic reactions with a second alkali reagent in second solvent to produce a second compound, finally the second compound reacts with a methylation reagent in the presence of a third alkali reagent in third solvent to obtain 2-(3,5-bi-trifluoromethyl-phenyl)-2-methyl-propionic acid. The Netupitant intermediate is prepared through a one-pot method, the used raw materials are easy to obtain and low in cost, and the synthetic method is short in reaction flow path, easy to operate, low in production cost and convenient to apply to industrial production.

Description

How appropriate one pyrrole smooth intermediate 2-(3,5-be two-trifluoromethyl-phenyl) and the synthetic method of-2-rnethyl-propanoic acid
Technical field
The present invention relates to a kind of synthesis how appropriate pyrrole smooth (NETUPITANT) intermediate 2-(3,5-two-trifluoromethyl-phenyl) method of-2-rnethyl-propanoic acid, belong to technical field of medicine synthesis.
Background technology
How appropriate pyrrole smooth (NETUPITANT) is one of effective constituent of the compound medicine Akynzeo defending the exploitation of material (Eisai) company, is can the new drug of the effective nausea and vomiting that preventing cancer chemotherapy acute phase and lag period, (starting in chemotherapy 25-120 hour) produced.Its English commodity are called Netupitant, English language Chemical name is called: 2-[3,5-bis (trifluoromethyl) phenyl]-N, 2-dimethyl-N-[4-(2-methylphenyl)-6-(4-methylpiperazin-1-yl) pyridin-3-yl] propanamide.
Molecular structural formula is as follows:
As one of the effective constituent of compound medicine Akynzeo, Akynzeo's is granted, is the data based on 2 clinical trials, and these researchs relate to the cancer patients that 1720 examples accept chemotherapy.First term research shows, in acute phase (in 24 hours), Akynzeo treatment group has the patient of 98.5% how to vomit without successive or need extra medicine support, and Aloxi treatment group Proportion of patients is 89.7%.In addition, this research also have recorded the ability that 2 kinds of medicines were felt sick with treatment in lag period and the omnidistance prevention of emesis of chemotherapy.Data show, in lag period and chemotherapy whole process, Akynzeo treatment group has the patient of 90.4% and 80.6% respectively without what vomiting successive, and Aloxi treatment group ratio is respectively 80.1% and 76.5%, and result for the treatment of is remarkable.
At present, how the synthetic method of appropriate pyrrole smooth (NETUPITANT) can realize (US8426450B1) according to following reaction scheme:
Can find from said synthesis route, how appropriate pyrrole smooth (NETUPITANT) intermediate 2-(3,5-is two-trifluoromethyl-phenyl) and-2-rnethyl-propanoic acid (hereinafter referred to as chemical compounds I) is the important intermediate of synthesizing how appropriate pyrrole smooth (NETUPITANT), its molecular structural formula is as follows:
How the important intermediate of appropriate pyrrole smooth (NETUPITANT), namely the synthetic method of compound 1 can be prepared by following route:
Existing method synthetic compound 1, need five step reactions, reaction time is long, and uses methyl iodide as methylating reagent, and harmful, expensive, thus this route well can not be applicable to suitability for industrialized production.
Summary of the invention
For solving the deficiencies in the prior art, the object of the present invention is to provide a kind of reactions steps short, process control, aftertreatment is simple, and yield is high, and can the synthetic method of cinacalcet intermediate 3-(3-trifluoromethyl) propyl alcohol of operate continuously.
In order to realize above-mentioned target, the present invention adopts following technical scheme:
How appropriate one pyrrole smooth intermediate 2-(3,5-be two-trifluoromethyl-phenyl) and the synthetic method of-2-rnethyl-propanoic acid, it is characterized in that, comprise the following steps:
With such as formula two (trifluoromethyl) bromobenzene of the compound 3.5-shown in II for raw material, deposit at the first alkali reagent and in the first solvent, react 1-24h with diethyl malonate in case, preferred 8-10h, temperature of reaction be 0 DEG C to the first solvent reflux temperature, preferably 90 DEG C, generate such as formula the compound one shown in III, then by compound one in the second solvent, saponification is carried out by the second alkali reagent, decarboxylic reaction 1-24h generates such as formula the compound two shown in IV, preferred 4-6h, temperature of reaction is room temperature to the second solvent reflux temperature, finally compound two is deposited at the 3rd alkali reagent and in the 3rd solvent, react 1-24h with methylating reagent in case, preferred 6-10h, temperature of reaction be-5 DEG C to the 3rd solvent reflux temperature, obtain such as formula the 2-(3 shown in I, 5-pair-trifluoromethyl-phenyl)-2-rnethyl-propanoic acid.
Further, the first above-mentioned alkali reagent is sodium hydride, sodium hydroxide, potassium hydroxide, potassium tert.-butoxide, sodium tert-butoxide, sodium methylate, any one in sodium ethylate, preferred sodium hydride.
And the amount of substance of the first above-mentioned alkali reagent and two (trifluoromethyl) bromobenzene of 3.5-is than being (1-2): 1, the amount of preferred substance is than being 1.5:1, and the amount of substance of described diethyl malonate and two (trifluoromethyl) bromobenzene of 3.5-is than being (1-2): 1, the amount of preferred substance is than being 1.3:1.
And the first described solvent is any one in dimethyl sulfoxide (DMSO), DMF, Isosorbide-5-Nitrae-dioxane, toluene, dimethylbenzene, preferred Isosorbide-5-Nitrae-dioxane.
Further, the second above-mentioned alkali reagent is any one in lithium hydroxide, sodium hydroxide, potassium hydroxide, preferred sodium hydroxide, and the second alkali reagent is (1-5) with the amount of substance ratio of compound one: 1, preferred 4.0:1.
And the second described solvent is any one in methylene dichloride, toluene, acetonitrile, water, tetrahydrofuran (THF), methyl alcohol, ethanol, propyl carbinol, particular methanol.
In addition, the 3rd described alkali reagent is sodium hydride, potassium tert.-butoxide, sodium tert-butoxide, sodium methylate, any one in sodium ethylate, preferred sodium hydride.
And the 3rd described alkali reagent is (1-4) with the ratio of the amount of substance of compound two: 1, preferred 2.5:1, and described methylating reagent is (1-3.5) with the ratio of the amount of substance of compound two: 1, preferred 1.5:1.
And the 3rd described solvent is any one in dimethyl sulfoxide (DMSO), DMF, Isosorbide-5-Nitrae-dioxane, toluene, dimethylbenzene, acetonitrile, tetrahydrofuran (THF), preferred tetrahydrofuran (THF).
Described methylating reagent is methylcarbonate or methyl-sulfate, preferably sulfuric acid dimethyl ester.
Usefulness of the present invention is: the present invention is by adopting the one kettle way preparation how smooth intermediate of appropriate pyrrole, and not only used raw material is easy to get, with low cost, and reaction process is short, and simple to operate, production cost is low, is convenient to suitability for industrialized production application.
Accompanying drawing explanation
Fig. 1 is the HPLC spectrogram of product of the present invention;
Fig. 2 is the nucleus magnetic hydrogen spectrum figure of product of the present invention.
Embodiment
Below in conjunction with specific embodiment, concrete introduction is done to the present invention.
Embodiment 1
Diethyl malonate (355g, 2.218mol) is added, N in reactor, dinethylformamide 1.5L, ice bath is cooled to 0 DEG C, stirs, adds sodium hydride (102.4g in batches, 2.559mol), finish equality of temperature and stir 1h, in reaction solution, add two (trifluoromethyl) bromobenzene (500g, 1.706mol) of compound 3.5-, be warming up to 90 DEG C, reaction 10h.Cooling, adds 4L water, divides three extractions, anhydrous sodium sulfate drying by 5L ethyl acetate, filters and is spin-dried for and obtains crude product (670.28g), not purifiedly directly carries out next step and reacts.
Under room temperature, in reactor, add crude Compound one (670.3gg, 1.706mol), methyl alcohol 2.5L, sodium hydroxide (272.5g, 6.812mol), stir and be warming up to backflow, reaction 5h.Cooling, be spin-dried for solvent, divide three extractions, anhydrous sodium sulfate drying with ethyl acetate 4L after acid adjustment, be spin-dried for and obtain crude Compound two (523.16g), not purified directly carry out next step react.
Under room temperature, crude Compound two (523.2g is dropped into successively in reaction flask, 1.706mol), N, dinethylformamide 5L,-5 DEG C add sodium hydride (170g in batches, 4.265mol), equality of temperature stirs 1h, drip methyl-sulfate (363.2g, 2.559mol), 50 DEG C of reaction 10h, be cooled to 10 DEG C and drip 4L sodium hydroxide (204.7g, 5.118mol) solution, drip and finish, 50 DEG C of reaction 4h, be cooled to room temperature, pressure reducing and steaming solvent, a large amount of solid is separated out in acid adjustment, filter, white solid 2-(3 is obtained by sherwood oil re-crystallizing in ethyl acetate after drying, 5-pair-trifluoromethyl-phenyl) the total molar yield of-2-rnethyl-propanoic acid 320.2g(three-step reaction: 62.5%).
Embodiment 2
Diethyl malonate (355g, 2.218mol) is added, Isosorbide-5-Nitrae-dioxane 1.5L in reactor.Ice bath is cooled to 0 DEG C, stirs, adds potassium tert.-butoxide (287g, 2.559mol) in batches, finishes equality of temperature and stirs 1h, adds two (trifluoromethyl) bromobenzene (500g, 1.706mol) of compound 3.5-, is warming up to 100 DEG C, reaction 10h to reaction solution.Cooling, adds 4L water, divides three extractions, anhydrous sodium sulfate drying by 5L ethyl acetate, filters and is spin-dried for and obtains crude Compound one (678.54g), not purifiedly directly carries out next step and reacts.
Under room temperature, in reactor, add crude Compound 3(678.5g, 1.706mol), ethanol 3L, sodium hydroxide (272.5g, 6.812mol), stirs the only backflow that heats up, reaction 6h.Be spin-dried for solvent, divide three extractions, anhydrous sodium sulfate drying with ethyl acetate 4L after acid adjustment, be spin-dried for and obtain crude Compound two (516.97g), not purified directly carry out next step reaction.
Under room temperature, crude Compound two (517g is dropped into successively in reaction flask, 1.706mol), tetrahydrofuran (THF) 5L,-5 DEG C add sodium hydrogen (170.6g in batches, 4.265mol), equality of temperature stirs 1h, drip methyl-sulfate (322.7g, 2.559mol), 50 DEG C of reaction 10h, be cooled to 10 DEG C and drip 4L sodium hydroxide (204.7g, 5.118mol) solution, drip and finish, 50 DEG C of reaction 4h, be cooled to room temperature, pressure reducing and steaming solvent, a large amount of solid is separated out in acid adjustment, filter, white solid 2-(3 is obtained by sherwood oil re-crystallizing in ethyl acetate after drying, 5-pair-trifluoromethyl-phenyl)-2-rnethyl-propanoic acid 317.5g, (the total molar yield of three-step reaction is 62.0%).
Embodiment 3
Diethyl malonate (355.2g, 2.218mol) is added, toluene 1.5L in reactor.Ice bath is cooled to 5 DEG C, stirs, adds sodium hydride (102g, 2.559mol) in batches, finishes equality of temperature and stirs 1h, adds two (trifluoromethyl) bromobenzene (500g, 1.706mol) of compound 3.5-, is warming up to 90 DEG C, reaction 10h to reaction solution.Cooling, adds 4L water, separatory, divides three extractions, anhydrous sodium sulfate drying by 5L ethyl acetate, filters and is spin-dried for and obtains crude Compound one (675.51g), not purifiedly directly carries out next step and reacts.
Under room temperature, in reactor, add crude Compound 3(675.6g, 1.706mol), methyl alcohol 2.5L, potassium hydroxide (382.2g, 6.812mol), stirs the only backflow that heats up, reaction 4h.Be spin-dried for solvent, divide three extractions, anhydrous sodium sulfate drying with ethyl acetate 4L after acid adjustment, be spin-dried for and obtain crude Compound two (530.47g), not purified directly carry out next step reaction.
Under room temperature, crude Compound 4(530.5g is dropped into successively in reaction flask, 1.706mol), tetrahydrofuran (THF) 5L,-5 DEG C add sodium hydrogen (170.6g in batches, 4.265mol), equality of temperature stirs 1h, drip methyl-sulfate (322.7g, 2.559mol), 50 DEG C of reaction 10h, be cooled to 10 DEG C and drip 4L sodium hydroxide (204.7g, 5.118mol) solution, drip and finish, 50 DEG C of reaction 4h, be cooled to room temperature, pressure reducing and steaming solvent, a large amount of solid is separated out in acid adjustment, filter, white solid 2-(3 is obtained by sherwood oil re-crystallizing in ethyl acetate after drying, 5-is two-trifluoromethyl-phenyl) the total molar yield of-2-rnethyl-propanoic acid 325.1g(three-step reaction is 63.5%).
Fig. 1 is the HPLC spectrogram of product of the present invention; Fig. 2 is the nucleus magnetic hydrogen spectrum figure of product of the present invention.
-2-rnethyl-propanoic acid as depicted in figs. 1 and 2: products therefrom of the present invention is 2-(3,5-pair-trifluoromethyl-phenyl), and purity is greater than 99.5%.
More than show and describe ultimate principle of the present invention, principal character and advantage.The technician of the industry should understand, and above-described embodiment does not limit the present invention in any form, the technical scheme that the mode that all employings are equal to replacement or equivalent transformation obtains, and all drops in protection scope of the present invention.

Claims (10)

1. how appropriate pyrrole smooth an intermediate 2-(3,5-two-trifluoromethyl-phenyl) synthetic method of-2-rnethyl-propanoic acid, it is characterized in that, comprise the following steps:
With such as formula two (trifluoromethyl) bromobenzene of the compound 3.5-shown in II for raw material, deposit at the first alkali reagent and in the first solvent, react 1-24h with diethyl malonate in case, temperature of reaction be 0 DEG C to the first solvent reflux temperature, generate such as formula the compound one shown in III, then by compound one in the second solvent, saponification is carried out by the second alkali reagent, decarboxylic reaction 1-24h generates such as formula the compound two shown in IV, temperature of reaction is room temperature to the second solvent reflux temperature, finally compound two is deposited at the 3rd alkali reagent and in the 3rd solvent, react 1-24h with methylating reagent in case, temperature of reaction be-5 DEG C to the 3rd solvent reflux temperature, obtain such as formula the 2-(3 shown in I, 5-pair-trifluoromethyl-phenyl)-2-rnethyl-propanoic acid.
2. the smooth intermediate 2-(3 of the how appropriate pyrrole of one according to claim 1,5-is two-trifluoromethyl-phenyl) and the synthetic method of-2-rnethyl-propanoic acid, it is characterized in that, the first described alkali reagent is sodium hydride, sodium hydroxide, potassium hydroxide, potassium tert.-butoxide, sodium tert-butoxide, sodium methylate, any one in sodium ethylate.
3. the smooth intermediate 2-(3 of the how appropriate pyrrole of one according to claim 1 and 2,5-is two-trifluoromethyl-phenyl) and the synthetic method of-2-rnethyl-propanoic acid, it is characterized in that, the amount of substance of the first described alkali reagent and two (trifluoromethyl) bromobenzene of 3.5-is than being (1-2): 1, and the amount of substance of described diethyl malonate and two (trifluoromethyl) bromobenzene of 3.5-is than being (1-2): 1.
4. the smooth intermediate 2-(3 of the how appropriate pyrrole of one according to claim 1,5-is two-trifluoromethyl-phenyl) and the synthetic method of-2-rnethyl-propanoic acid, it is characterized in that, the first described solvent is dimethyl sulfoxide (DMSO), N, any one in dinethylformamide, Isosorbide-5-Nitrae-dioxane, toluene, dimethylbenzene.
5. the smooth intermediate 2-(3 of the how appropriate pyrrole of one according to claim 1,5-is two-trifluoromethyl-phenyl) and the synthetic method of-2-rnethyl-propanoic acid, it is characterized in that, the second described alkali reagent is any one in lithium hydroxide, sodium hydroxide, potassium hydroxide, and the second described alkali reagent is (1-5) with the amount of substance ratio of compound one: 1.
6. the smooth intermediate 2-(3 of the how appropriate pyrrole of one according to claim 1,5-is two-trifluoromethyl-phenyl) and the synthetic method of-2-rnethyl-propanoic acid, it is characterized in that, the second described solvent is any one in methylene dichloride, toluene, acetonitrile, water, tetrahydrofuran (THF), methyl alcohol, ethanol, propyl carbinol.
7. the smooth intermediate 2-(3 of the how appropriate pyrrole of one according to claim 1,5-is two-trifluoromethyl-phenyl) and the synthetic method of-2-rnethyl-propanoic acid, it is characterized in that, the 3rd described alkali reagent is sodium hydride, potassium tert.-butoxide, sodium tert-butoxide, sodium methylate, any one in sodium ethylate.
8. the smooth intermediate 2-(3 of the how appropriate pyrrole of the one according to claim 1 or 8,5-is two-trifluoromethyl-phenyl) and the synthetic method of-2-rnethyl-propanoic acid, it is characterized in that, the 3rd described alkali reagent is (1-4) with the ratio of the amount of substance of compound two: 1, and described methylating reagent is (1-3.5) with the ratio of the amount of substance of compound two: 1.
9. the smooth intermediate 2-(3 of the how appropriate pyrrole of one according to claim 1,5-is two-trifluoromethyl-phenyl) and the synthetic method of-2-rnethyl-propanoic acid, it is characterized in that, the 3rd described solvent is dimethyl sulfoxide (DMSO), N, any one in dinethylformamide, Isosorbide-5-Nitrae-dioxane, toluene, dimethylbenzene, acetonitrile, tetrahydrofuran (THF).
10. the how appropriate pyrrole of one according to claim 1 smooth intermediate 2-(3,5-two-trifluoromethyl-phenyl) synthetic method of-2-rnethyl-propanoic acid, it is characterized in that, described methylating reagent is methylcarbonate or methyl-sulfate.
CN201610013748.4A 2016-01-11 2016-01-11 Synthetic method for Netupitant intermediate 2-(3,5-bi-trifluoromethyl-phenyl)-2-methyl-propionic acid Pending CN105503569A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610013748.4A CN105503569A (en) 2016-01-11 2016-01-11 Synthetic method for Netupitant intermediate 2-(3,5-bi-trifluoromethyl-phenyl)-2-methyl-propionic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610013748.4A CN105503569A (en) 2016-01-11 2016-01-11 Synthetic method for Netupitant intermediate 2-(3,5-bi-trifluoromethyl-phenyl)-2-methyl-propionic acid

Publications (1)

Publication Number Publication Date
CN105503569A true CN105503569A (en) 2016-04-20

Family

ID=55711944

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610013748.4A Pending CN105503569A (en) 2016-01-11 2016-01-11 Synthetic method for Netupitant intermediate 2-(3,5-bi-trifluoromethyl-phenyl)-2-methyl-propionic acid

Country Status (1)

Country Link
CN (1) CN105503569A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107721815A (en) * 2017-09-21 2018-02-23 爱斯特(成都)生物制药股份有限公司 The preparation method of one kind 2 (3,5 2 (trifluoromethyl) phenyl) 2 methylpropanoic acids of synthesis

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001302582A (en) * 2000-04-17 2001-10-31 Central Glass Co Ltd Method for producing trifluoromethylphenylacetic acid
WO2001087838A1 (en) * 2000-05-19 2001-11-22 Merck Sharp & Dohme Limited Cyclohexane derivatives and their use as therapeutic agents
JP2002069038A (en) * 2000-08-29 2002-03-08 Seimi Chem Co Ltd Trifluoromethyl group-bearing benzoylformic alkyls, method of producing the same and method of trifluoromethyl group-bearing phenylacetic acid
US6395921B1 (en) * 1999-08-16 2002-05-28 Bayer Aktiengesellschaft Process for preparing [bis-(trifluoromethyl)-phenyl]-acetic acids and alkyl esters thereof and dialkyl [bis-(trifluoromethyl)-phenyl]-malonates
CN1491200A (en) * 2001-02-13 2004-04-21 - Process for manufacture of phenylacetic acid derivatives
CN103508888A (en) * 2013-09-17 2014-01-15 北京石油化工学院 Synthetic method of 2,2-dimethyl dimethylmalonate

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395921B1 (en) * 1999-08-16 2002-05-28 Bayer Aktiengesellschaft Process for preparing [bis-(trifluoromethyl)-phenyl]-acetic acids and alkyl esters thereof and dialkyl [bis-(trifluoromethyl)-phenyl]-malonates
JP2001302582A (en) * 2000-04-17 2001-10-31 Central Glass Co Ltd Method for producing trifluoromethylphenylacetic acid
WO2001087838A1 (en) * 2000-05-19 2001-11-22 Merck Sharp & Dohme Limited Cyclohexane derivatives and their use as therapeutic agents
JP2002069038A (en) * 2000-08-29 2002-03-08 Seimi Chem Co Ltd Trifluoromethyl group-bearing benzoylformic alkyls, method of producing the same and method of trifluoromethyl group-bearing phenylacetic acid
CN1491200A (en) * 2001-02-13 2004-04-21 - Process for manufacture of phenylacetic acid derivatives
CN103508888A (en) * 2013-09-17 2014-01-15 北京石油化工学院 Synthetic method of 2,2-dimethyl dimethylmalonate

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
FABIENNE HOFFMANN-EMERY 等: "Efficient Synthesis of Novel NK1 Receptor Antagonists: Selective 1,4-Addition of Grignard Reagents to 6-Chloronicotinic Acid Derivatives", 《J. ORG. CHEM.》 *
LI SUN等: "Synthesis and Biological Evaluations of 3-Substituted Indolin-2-ones: A Novel Class of Tyrosine Kinase Inhibitors That Exhibit Selectivity toward Particular Receptor Tyrosine Kinases", 《J. MED. CHEM.》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107721815A (en) * 2017-09-21 2018-02-23 爱斯特(成都)生物制药股份有限公司 The preparation method of one kind 2 (3,5 2 (trifluoromethyl) phenyl) 2 methylpropanoic acids of synthesis

Similar Documents

Publication Publication Date Title
DK2538785T3 (en) Methods for the synthesis of diarylthiohydantoin and diarylhydantoin compounds
CN106608876B (en) A kind of preparation method of high-purity Pa Boxini
CN111848607B (en) Novel BCL-2/BCL-XL inhibitor, pharmaceutical composition and application
CN113603568A (en) Preparation method of cannabidiol
CN104926775A (en) Preparation method of fluorine-containing pyran derivative
CN104926798A (en) High purity preparation method of Afatinib intermediate
CN108546253B (en) Method for multi-step synthesis of 2-benzyl-1, 5-dihydrobenzo [ e ] [1,4] oxazepine
CN105503569A (en) Synthetic method for Netupitant intermediate 2-(3,5-bi-trifluoromethyl-phenyl)-2-methyl-propionic acid
CN107226777A (en) A kind of synthetic method of 1,2 biphenoxyl ethane temperature-sensitive sensitizers
CN104829575A (en) Preparation method of 6-fluoropyran derivative
CN104860910A (en) Preparation method of 8-fluoropyran derivative
CN104744377A (en) Preparation method of (E)-3-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methanesulfonylamino) pyrimidine-5-yl] acrolein
CN104829574A (en) 8-bromo pyran derivative preparation method
CN104844549A (en) Preparation method of 7 - bromine pyran derivatives
CN104829576A (en) Preparation method of 7-fluoropyran derivatives
CN105273006A (en) Method for preparing 2-dicyclohexylphosphine-2,4,6-di-iso-propylbiphenyl
CN107200729B (en) Preparation method of 4- (2-methoxyphenyl) -5- (2-pyridyl) -3-aminoisoxazole
CN104230723A (en) Synthesis method of toremifene
CN106038560A (en) Application of sulfur-containing andrographolide derivatives in preparing medicines for treating prostatic cancer
CN104151278B (en) The synthetic method of 1-phenyl-2,3-naphthalene dicarboxylic acids acid anhydride and derivative thereof
CN103936662B (en) 1-R1-3, 3-difluoro-4-R2-piperidine and its derivatives and its prepn
CN110642689B (en) 3, 6-dibromo-2-methylbenzaldehyde and chemical synthesis method thereof
CN108774190B (en) Method for multi-step synthesis of 2-benzyl-1, 5-dihydrobenzo [ e ] [1,4] oxazepine
JP6256469B2 (en) Process for the preparation of spiro [2.5] octane-5,7-dione
KR101418776B1 (en) Selenophene-fused aromatic compounds, and preparing method of the same

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20160420